Exelon Corporation
$95.13B- Market cap
- $44.66B
- Debt
- +$51.09B
- Cash
- −$626.00M
Capital structure 47% equity / 53% debt · EV / Revenue 3.92x · EV / EBITDA 11.38x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: EXC stock price at discount vs TTI $43.66 current versus $936.20 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TTI's multiple
Implied fair value · at EXC's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Value edge
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EXC FY 2025 (ended Dec 31, 2025) · TTI FY 2025 (ended Dec 31, 2025).
Trendline
11 fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 47% equity / 53% debt · EV / Revenue 3.92x · EV / EBITDA 11.38x
Capital structure 84% equity / 16% debt · EV / Revenue 1.81x · EV / EBITDA 15.00x
EXC carries the larger enterprise value at $95.13B against $1.14B; TTI trades on the lower EV / Revenue multiple (1.81x vs 3.92x); EXC on the lower EV / EBITDA (11.38x vs 15.00x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
EXELON CORPORATION · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
TETRA Technologies, Inc. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.77x
0.67x
Net debt / EBITDA
Leverage against operating earnings
6.04x
1.54x
Cash and equivalents
Liquid reserves on the balance sheet
$626.00M
$72.63M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
$51.09B
$190.00M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.